Interestingly, our public data analysis revealed that GPx4 is overexpressed in the ovaries of patients with ovarian cancer compared with that in healthy women with epithelial ovaries, and patients with altered GPx4 levels displayed a longer overall survival than the unaltered groups, suggesting that GPx4 status can play an important role in ovarian cancer progression. Here, GPX4 is linked to ovarian carcinoma.